Nargoran (Cetirizine Dihydrochloride)

Cetirizine selectively antagonizes peripheral H1 receptors. By occupying the histamine binding site on mast cells and basophils, it prevents histamine‑induced vasodilation, increased vascular permeability and nerve stimulation. This inhibition curtails the early allergic response, diminishing symptoms such as itching, swelling and nasal congestion while largely sparing central nervous system receptors, which limits sedation.

The specific dose of Nargoran is determined by the prescribing healthcare professional based on the patient’s age, condition severity and renal function. Typical adult dosing ranges from 10 mg once daily, but exact strength and regimen should follow the prescriber’s instructions and local labeling. Patients should not adjust the dose without medical advice.

Safety data for cetirizine during pregnancy and lactation are limited. It is classified as Category B in some regions, indicating no proven risk in animal studies, but human data are insufficient. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential benefits and risks with their healthcare provider before using Nargoran.

To request Nargoran, visit the product page on gnhindia.com, enter the desired quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements) and necessary import documentation.

Compared with first‑generation antihistamines such as diphenhydramine, cetirizine offers similar efficacy in relieving allergic symptoms but with a lower incidence of sedation because it penetrates the central nervous system to a lesser extent. Among second‑generation agents, its potency is comparable to loratadine and fexofenadine, though individual response and tolerability may vary.

Nargoran tablets should be stored at room temperature, below 25 °C (77 °F). Keep them in the original blister pack or container to protect from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children. No refrigeration is required.

Nargoran is taken orally, usually with a glass of water. The tablet may be swallowed with or without food; taking it with food can reduce occasional stomach discomfort. Patients should follow the dosage prescribed by their healthcare professional and avoid crushing or chewing the tablet unless instructed otherwise.

Although rare, serious adverse reactions can occur. Patients should seek immediate medical attention if they notice signs of anaphylaxis such as difficulty breathing, swelling of the face or throat, or a rash that spreads rapidly. Other severe events include Stevens‑Johnson syndrome, liver injury, blood disorders and angioedema. Prompt reporting of any unexpected symptoms is essential.

Nargoran is contraindicated in individuals with known hypersensitivity to cetirizine or any excipients in the formulation. Caution is advised for patients with severe renal impairment, as dose adjustment may be required. It should also be used carefully in the elderly and in those taking other sedating medications. Pregnant or breastfeeding women should consult a physician before use.